We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEG icon
376
Public Service Enterprise Group
PEG
$38.7B
$4.36M 0.03%
65,259
+23,628
+57% +$1.5M
SONY icon
377
Sony
SONY
$137B
$4.32M 0.03%
171,035
-18,900
-10% -$450K
FISV
378
Fiserv Inc
FISV
$29.7B
$4.32M 0.03%
41,584
-6,037
-13% -$624K
ERIC icon
379
Ericsson
ERIC
$32.1B
$4.31M 0.03%
396,862
+40,652
+11% +$444K
ASMB icon
380
Assembly Biosciences
ASMB
$498M
$4.28M 0.03%
153,185
+30,781
+25% +$1.01M
CNI icon
381
Canadian National Railway
CNI
$78.5B
$4.28M 0.03%
34,807
-6,566
-16% -$832K
GMED icon
382
Globus Medical
GMED
$11.1B
$4.26M 0.03%
59,000
– –
PSA icon
383
Public Storage
PSA
$61.5B
$4.25M 0.03%
11,350
-8,122
-42% -$2.71M
D icon
384
Dominion Energy
D
$62.1B
$4.24M 0.03%
53,980
-3,320
-6% -$250K
FMTX
385
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$4.16M 0.03%
292,692
– –
RARE icon
386
Ultragenyx Pharmaceutical
RARE
$2.46B
$4.16M 0.03%
49,480
– –
AVTR icon
387
Avantor
AVTR
$9.73B
$4.15M 0.03%
98,413
-190,019
-66% -$7.49M
NGNE icon
388
Neurogene
NGNE
$672M
$4.14M 0.03%
42,909
– –
CVX icon
389
Chevron
CVX
$382B
$4.12M 0.03%
35,084
-3,634
-9% -$413K
PODD icon
390
Insulet
PODD
$11.8B
$4.1M 0.03%
15,423
+11,568
+300% +$3.36M
CMI icon
391
Cummins
CMI
$83.6B
$4.1M 0.03%
18,793
+2,844
+18% +$648K
SLB icon
392
SLB Ltd
SLB
$72.7B
$4.09M 0.03%
136,715
-476,285
-78% -$15M
PCAR icon
393
PACCAR
PCAR
$70.5B
$4.07M 0.03%
61,511
-4,330
-7% -$250K
XYZ
394
Block Inc
XYZ
$48.9B
$4.04M 0.03%
25,033
-2,750
-10% -$596K
SBAC icon
395
SBA Communications
SBAC
$19.8B
$4.04M 0.03%
10,373
+3,126
+43% +$1.1M
PVLA
396
Palvella Therapeutics
PVLA
$2.05B
$4.01M 0.03%
13,273
– –
DEO icon
397
Diageo
DEO
$49.6B
$3.97M 0.03%
18,046
– –
DHI icon
398
D.R. Horton
DHI
$41.2B
$3.93M 0.03%
36,274
-1,059
-3% -$102K
MET icon
399
MetLife
MET
$62.4B
$3.93M 0.03%
62,832
-5,813
-8% -$365K
ARWR icon
400
Arrowhead Research
ARWR
$12.1B
$3.92M 0.03%
59,187
-137,221
-70% -$9.43M
14 15
16
17 18

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.